S. Korea Approves MSD’s Oral COVID-19 Pill for At-risk Patients

SEOUL, March 23 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday granted an emergency authorization of multinational pharmaceutical company MSD’s oral drug to treat COVID-19, making it the second such pill to be used in the country. Lagevrio is the antiviral pill for the treatment of mild to moderate COVID-19 patients at increased [...]